LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-19.63% | 11.48 Mrd. | |
+41.70% | 3.27 Mrd. | |
-36.19% | 2.2 Mrd. | |
-18.92% | 2.05 Mrd. | |
-28.28% | 1.49 Mrd. | |
+14.73% | 1.01 Mrd. | |
-4.37% | 743 Mio. | |
-36.75% | 413 Mio. | |
-47.45% | 377 Mio. |